Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Identification and Characterization of Host Proteins Hijacked by the Human Immunodeficiency Virus
EF 2018-19
Résumé
Human immunodeficiency virus (HIV) currently affects 37 million people worldwide and has led to over 35 million deaths. Although antiretroviral treatments (ART) can control viral replication, they cannot cure infection. As nascent virions bud through the cellular membranes of the CD4+ T cells that they infect, they can acquire cellular host proteins which become embedded in the viral envelope. Key host proteins are selectively incorporated by virions that can alter viral homing and infectivity.
Integrin ?4?7 is an adhesion protein on CD4+ T cells that facilitates homing to the gut through interactions with gut-resident mucosal adhesion molecules. Virions that incorporate ?4?7 effectively hijack the homing mechanism used by T cells to migrate to the gut. This allows HIV virions to rapidly infect and deplete CD4+ T cells, as the gut is the largest reservoir for CD4+ T cells, likely leading to accelerated disease progression in HIV-infected individuals. Primate studies highlight the importance of the integrin during infection by showing that blocking ?4?7 homing with an anti-?4?7 antibody can delay disease progression and provide persistent control of viral infection, even in the absence of ART. The mechanism(s) behind these findings is unknown and is the topic of my proposal.
My research aims to investigate how ?4?7 integrin becomes selectively enriched in HIV virions, with a goal of characterizing the viral determinants underpinning ?4?7 incorporation. I also plan to characterize new unidentified host proteins in the viral envelope that may also impact HIV infectivity and homing. Collectively, these findings may help identify new targets on virions that can be used for novel drug and vaccine designs, which may help reduce the burden of HIV in Canada and worldwide.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406403
Name
Burnie Jonathan D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identification and Characterization of Host Proteins Hijacked by the Human Immunodeficiency Virus
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aids; Alpha4-Beta7 Integrin; Hiv; Host Proteins; Selective Incorporation; Viral Envelope; Virology
Abstract
Human immunodeficiency virus (HIV) currently affects 37 million people worldwide and has led to over 35 million deaths. Although antiretroviral treatments (ART) can control viral replication, they cannot cure infection. As nascent virions bud through the cellular membranes of the CD4+ T cells that they infect, they can acquire cellular host proteins which become embedded in the viral envelope. Key host proteins are selectively incorporated by virions that can alter viral homing and infectivity.
Integrin ?4?7 is an adhesion protein on CD4+ T cells that facilitates homing to the gut through interactions with gut-resident mucosal adhesion molecules. Virions that incorporate ?4?7 effectively hijack the homing mechanism used by T cells to migrate to the gut. This allows HIV virions to rapidly infect and deplete CD4+ T cells, as the gut is the largest reservoir for CD4+ T cells, likely leading to accelerated disease progression in HIV-infected individuals. Primate studies highlight the importance of the integrin during infection by showing that blocking ?4?7 homing with an anti-?4?7 antibody can delay disease progression and provide persistent control of viral infection, even in the absence of ART. The mechanism(s) behind these findings is unknown and is the topic of my proposal.
My research aims to investigate how ?4?7 integrin becomes selectively enriched in HIV virions, with a goal of characterizing the viral determinants underpinning ?4?7 incorporation. I also plan to characterize new unidentified host proteins in the viral envelope that may also impact HIV infectivity and homing. Collectively, these findings may help identify new targets on virions that can be used for novel drug and vaccine designs, which may help reduce the burden of HIV in Canada and worldwide.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Burnie, Jonathan D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~